These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 18362098

  • 1. Activity-dependent excitability changes suggest Na+/K+ pump dysfunction in diabetic neuropathy.
    Krishnan AV, Lin CS, Kiernan MC.
    Brain; 2008 May; 131(Pt 5):1209-16. PubMed ID: 18362098
    [Abstract] [Full Text] [Related]

  • 2. Neuropathy, axonal Na+/K+ pump function and activity-dependent excitability changes in end-stage kidney disease.
    Krishnan AV, Phoon RK, Pussell BA, Charlesworth JA, Bostock H, Kiernan MC.
    Clin Neurophysiol; 2006 May; 117(5):992-9. PubMed ID: 16516547
    [Abstract] [Full Text] [Related]

  • 3. Ischaemia induces paradoxical changes in axonal excitability in end-stage kidney disease.
    Krishnan AV, Phoon RK, Pussell BA, Charlesworth JA, Bostock H, Kiernan MC.
    Brain; 2006 Jun; 129(Pt 6):1585-92. PubMed ID: 16636020
    [Abstract] [Full Text] [Related]

  • 4. Axonal function and activity-dependent excitability changes in myotonic dystrophy.
    Krishnan AV, Kiernan MC.
    Muscle Nerve; 2006 May; 33(5):627-36. PubMed ID: 16453325
    [Abstract] [Full Text] [Related]

  • 5. Dynamic change of proximal conduction in demyelinating neuropathies: a cervical magnetic stimulation combined with maximum voluntary contraction.
    Hitomi T, Kaji R, Murase N, Kohara N, Mezaki T, Nodera H, Kawamura T, Ikeda A, Shibasaki H.
    Clin Neurophysiol; 2007 Apr; 118(4):741-50. PubMed ID: 17317300
    [Abstract] [Full Text] [Related]

  • 6. Activity-induced weakness in recessive myotonia congenita with a novel (696+1G>A) mutation.
    McKay OM, Krishnan AV, Davis M, Kiernan MC.
    Clin Neurophysiol; 2006 Sep; 117(9):2064-8. PubMed ID: 16854622
    [Abstract] [Full Text] [Related]

  • 7. Axonal excitability properties in amyotrophic lateral sclerosis.
    Vucic S, Kiernan MC.
    Clin Neurophysiol; 2006 Jul; 117(7):1458-66. PubMed ID: 16759905
    [Abstract] [Full Text] [Related]

  • 8. Altered nerve excitability properties in established diabetic neuropathy.
    Krishnan AV, Kiernan MC.
    Brain; 2005 May; 128(Pt 5):1178-87. PubMed ID: 15758031
    [Abstract] [Full Text] [Related]

  • 9. Mutation in the Na+ channel subunit SCN1B produces paradoxical changes in peripheral nerve excitability.
    Kiernan MC, Krishnan AV, Lin CS, Burke D, Berkovic SF.
    Brain; 2005 Aug; 128(Pt 8):1841-6. PubMed ID: 15857929
    [Abstract] [Full Text] [Related]

  • 10. Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage.
    Kanai K, Kuwabara S, Misawa S, Tamura N, Ogawara K, Nakata M, Sawai S, Hattori T, Bostock H.
    Brain; 2006 Apr; 129(Pt 4):953-62. PubMed ID: 16467388
    [Abstract] [Full Text] [Related]

  • 11. Utilizing natural activity to dissect the pathophysiology of acute oxaliplatin-induced neuropathy.
    Park SB, Lin CS, Krishnan AV, Goldstein D, Friedlander ML, Kiernan MC.
    Exp Neurol; 2011 Jan; 227(1):120-7. PubMed ID: 20965170
    [Abstract] [Full Text] [Related]

  • 12. The acute effects of glycemic control on axonal excitability in human diabetics.
    Kitano Y, Kuwabara S, Misawa S, Ogawara K, Kanai K, Kikkawa Y, Yagui K, Hattori T.
    Ann Neurol; 2004 Oct; 56(4):462-7. PubMed ID: 15455400
    [Abstract] [Full Text] [Related]

  • 13. Hypothesis: low Na/K-ATPase activity in the red cell membrane, a potential marker of the predisposition to diabetic neuropathy.
    Raccah D, Gallice P, Pouget J, Vague P.
    Diabete Metab; 1992 Oct; 18(3):236-41. PubMed ID: 1327887
    [Abstract] [Full Text] [Related]

  • 14. Nerve excitability changes in critical illness polyneuropathy.
    Z'Graggen WJ, Lin CS, Howard RS, Beale RJ, Bostock H.
    Brain; 2006 Sep; 129(Pt 9):2461-70. PubMed ID: 16901913
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of Na+/K+ pump function following repetitive activity in mouse peripheral nerve.
    Moldovan M, Krarup C.
    J Neurosci Methods; 2006 Sep 15; 155(2):161-71. PubMed ID: 16466807
    [Abstract] [Full Text] [Related]

  • 16. Axonal dysfunction prior to neuropathy onset in type 1 diabetes.
    Arnold R, Kwai N, Lin CS, Poynten AM, Kiernan MC, Krishnan AV.
    Diabetes Metab Res Rev; 2013 Jan 15; 29(1):53-9. PubMed ID: 23008000
    [Abstract] [Full Text] [Related]

  • 17. The effect of hyperventilation on strength-duration properties in diabetic polyneuropathy.
    Yerdelen D, Uysal H, Koç F, Sarica Y.
    Clin Neurophysiol; 2007 Jan 15; 118(1):105-10. PubMed ID: 17095293
    [Abstract] [Full Text] [Related]

  • 18. C-peptide, Na+,K(+)-ATPase, and diabetes.
    Vague P, Coste TC, Jannot MF, Raccah D, Tsimaratos M.
    Exp Diabesity Res; 2004 Jan 15; 5(1):37-50. PubMed ID: 15198370
    [Abstract] [Full Text] [Related]

  • 19. Excitability differences in lower-limb motor axons during and after ischemia.
    Krishnan AV, Lin CS, Kiernan MC.
    Muscle Nerve; 2005 Feb 15; 31(2):205-13. PubMed ID: 15609346
    [Abstract] [Full Text] [Related]

  • 20. Increased nodal persistent Na+ currents in human neuropathy and motor neuron disease estimated by latent addition.
    Tamura N, Kuwabara S, Misawa S, Kanai K, Nakata M, Sawai S, Hattori T.
    Clin Neurophysiol; 2006 Nov 15; 117(11):2451-8. PubMed ID: 16996798
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.